organovo.com (ONVO) Market Value to Book Value Ratio

The P/B multiple history demonstrates the market valuation of Organovo Holdings, Inc. (ONVO). The value 8.17 describes the current asset valuation of this 3D bioprinting pioneer, whose revenue is based on B2B contracts with pharma behemoths. Management is developing therapeutic liver models to combat the shortage of transplants. Currently, the company is reallocating resources to create its own drugs for intestinal inflammation.

The value of Organovo Holdings, Inc. (ONVO) high-tech bioprinting laboratories in California is reflected through the ratio of market capitalization to book value. This metric compares the company's current market valuation with its net assets. An increase in this indicator signals a premium revaluation of intellectual capital by the market. This chart allows for the identification of overbought shares relative to tangible assets. The reservation of precision equipment confirms the fundamental stability of the business.